Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC
Clinical trial NCT06001567 · UNKNOWN
Trial details
- NCT number
- NCT06001567
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2024-08-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.